Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

To the disappointment of buy-and-hold investors, 2025 is shaping up to be a year where nimble traders are likely to see the ...

Novo Nordisk’s blockbuster GLP-1 products Ozempic and Wegovy are among the next 15 drugs subject to the government’s Medicare ...

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Following the strange year for the biopharma industry that was 2024, insiders and analysts alike are waiting expectantly to ...

Premium frozen side and vegetable options have done particularly well, up 3% and 11% in volume sales, respectively, versus ...

GLP-1 drug users initially spend less on groceries, but that levels out over the next year, shows Circana's analysis of food ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies ...

New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...